# Editorial: Systems biology, women in science 2021/22: translational systems biology and in silico trials

**Authors:** Jane A. Leopold, Madhavi K. Ganapathiraju, Naveena Yanamala

PMC · DOI: 10.3389/fsysb.2023.1293298 · Frontiers in Systems Biology · 2023-09-29

## Full-text entities

- **Diseases:** cardiovascular diseases (MESH:D002318), cervical, lung, or prostate cancer (MESH:D011471), myocardial infarction (MESH:D009203), lung damage (MESH:D008171), coronary artery stenosis (MESH:D023921), coronary artery disease (MESH:D003324), inflammatory (MESH:D007249), stenoses (MESH:D003251), malignancies (MESH:D009369), emphysema (MESH:D004646), COPD (MESH:D029424), malaria (MESH:D008288), infection (MESH:D007239), toxicity (MESH:D064420), Mtb infection (MESH:D014376), peripheral arterial disease (MESH:D058729), hypertension (MESH:D006973)
- **Chemicals:** Asphalt (MESH:C006647)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycobacterium tuberculosis (species) [taxon 1773], Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12341993/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12341993/full.md

---
Source: https://tomesphere.com/paper/PMC12341993